Media coverage of Cheri Mah, a TL1 fellow in CTSI's Clinical and Translational Research Fellowship Program (CTRFP) on elite athlete applications of her REST study.
After applying the tool and comparing the data with the biopsy findings, UCSF researchers reduced the number of benign biopsies or false-positives by 60%, from 55 to 22.